HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007–2010

REFERENCES

• Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18:2295–2303.
   PubMed Web of Science ®Google Scholar
• UNAIDS. AIDS Epidemic Update. Geneva: UNAIDS, 2003.
   Google Scholar
• World Health Organization. Report on the Global AIDS Epidemic. Geneva: UNAIDS, Geneva, 2009. Available at http://www.unaids.org/en/. Last accessed on January 12, 2012.
   Google Scholar
• Taiwan Centers for Disease Control and Prevention [Surveillance of HIV]. Available at http://www.cdc.gov.tw. Last accessed on January 23, 2012 [Chinese].
   Google Scholar
• Prevention CfDCa. Revised guidelines for HIV counseling, testing, and referral. MMWR Morb Mortal Wkly Rep 2001; 50:1–58.
   PubMedGoogle Scholar
• CDC. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Morb Mortal Wkly Rep 2003; 52:1–16.
   PubMedGoogle Scholar
• Marc B, Bouchez-Buvry A, Wepierre JL, Boniol L, Vaquero P, Garnier M. Carbon-monoxide poisoning in young drug addicts due to indoor use of a gasoline-powered generator. J Clin Forensic Med 2001; 8:54–56.
   PubMedGoogle Scholar
• Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86:655–661.
   PubMed Web of Science ®Google Scholar
• Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: Implication for transmission among injection drug users. J Infect Dis 2010; 202:984–990.
   PubMed Web of Science ®Google Scholar
• Doerrbecker J, Friesland M, Ciesek S, Erichsen TJ, Mateu-Gelabert P, Steinmann J, Pietschmann T, Steinmann E. Inactivation and survival of hepatitis C virus on inanimate surfaces. J Infect Dis 2011; 204:1830–1838.
   PubMed Web of Science ®Google Scholar
• Tjotta E, Hungnes O, Grinde B. Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying. J Med Virol 1991; 35:223–227.
   PubMed Web of Science ®Google Scholar
• Yu SK, Jiang DD, Chen KT. Drug abuse in Taiwan: A preliminary investigation. Taiwan Epidemiol Bull. 1996; 12:164–170.
   Google Scholar
• Lyu SY. HIV/AIDS Related Risk Assessment for Drug-Using Parolees. Taipei: National Science Council, 2001.
   Google Scholar
• Lee TSH. Prevalence and related factors of needle-sharing behavior among female prisoners. J Med Sci 2005; 25:27–32.
   Google Scholar
• Chakrapani V, Newman PA, Shunmugam M, Dubrow R. Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: A mixed methods investigation. Harm Reduct J 2011; 8:9.
   PubMed Web of Science ®Google Scholar
• Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet 2008; 372:1733–1745.
   PubMed Web of Science ®Google Scholar
• Mahanta J, Borkakoty B, Das HK, Chelleng PK. The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care 2009; 21:1420–1424.
   PubMed Web of Science ®Google Scholar
• Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 2009; 20:399–405.
   PubMed Web of Science ®Google Scholar
• NAPAC. Ungass Country Progress Report: Thailand. Bangkok: National AIDS Prevention and Alleviation Committee, 2010.
   Google Scholar
• Cheng SH, Chiang TL. The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. J Am Med Assoc 1997; 278:89–93.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, Williams I, Garfein RS. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003; 157:467–471.
   PubMed Web of Science ®Google Scholar
• Booth RE, Crowley TJ, Zhang Y. Substance abuse treatment entry, retention and effectiveness: Out-of-treatment opiate injection drug users. Drug Alcohol Depend 1996; 42:11–20.
   PubMed Web of Science ®Google Scholar
• McCusker J, Stoddard AM, Hindin RN, Garfield FB, Frost R. Changes in HIV risk behavior following alternative residential programs of drug abuse treatment and AIDS education. Ann Epidemiol 1996; 6:119–125.
   PubMed Web of Science ®Google Scholar
• Greenfield L, Bigelow GE, Brooner RK. Validity of intravenous drug abusers’ self-reported changes in HIV high-risk drug use behaviors. Drug Alcohol Depend 1995; 39:91–98.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski CF, Booth RE. Methadone maintenance as HIV risk reduction with street-recruited injecting drug users. J Acquir Immune Defic Syndr 2001; 26:483–489.
   PubMed Web of Science ®Google Scholar
• CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. Morb Mortal Wkly Rep. 2006; 55:1–17.
   PubMedGoogle Scholar
• Paltiel AD, Weinstein MC, Kimmel AD, Seage GR3rd, Losina E, Zhang H, Freedberg KA, Walensky RP. Expanded screening for HIV in the United States–an analysis of cost-effectiveness. N Engl J Med 2005; 352: 586–595.
   PubMed Web of Science ®Google Scholar
• Latkin CA, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998; 93:1191–1197.
   PubMed Web of Science ®Google Scholar
• Kissin DM, Zapata L, Yorick R, Vinogradova EN, Volkova GV, Cherkassova E, Lynch A, Leigh J, Jamieson DJ, Marchbanks PA, Hillis S. HIV seroprevalence in street youth, St. Petersburg, Russia. AIDS 2007; 21:2333–2340.
   PubMed Web of Science ®Google Scholar